| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/31/2008 | US20080027084 antiinflammatory agent, anticarcinogenic agent; for treating inflammatory diseases, allergic, autoimmune, metabolic, cancer, cardiovascular diseases |
| 01/31/2008 | US20080027083 Modulators of chemokine receptor activity crystalline forms and process |
| 01/31/2008 | US20080027081 Therapeutic compounds |
| 01/31/2008 | US20080027080 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/31/2008 | US20080027078 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 01/31/2008 | US20080027074 3-(2-piperazin-1-yl-phenylsulfanyl)-1H-indole; 3-(2-piperazin-1-yl-phenylsulfanyl)-1H-indole-7-carboxylic acid methyl ester; attention deficit hyperactivity disorder (ADHD); serotonin, norepinephrine and/or dopamine reuptake inhibitors reuptake inhibitors |
| 01/31/2008 | US20080027071 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 01/31/2008 | US20080027066 Arylpiperazinyl Compounds |
| 01/31/2008 | US20080027064 imidazo[1,5-a]pyrido[3,2-e]pyrazines; neurologic and psychiatric disorders, for example psychosis |
| 01/31/2008 | US20080027062 2-amino-4-N-cyclohexylmethylamino-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-pteridine; treatment of pathological blood pressure decreases, such as occur in septic or hemorrhagic shock, in tumor or cancer therapy with cytokines, liver cirrhosis; ulcerative colitis; NO synthase inhibitor |
| 01/31/2008 | US20080027057 Use of dihydroimidazolones for the treatment of dogs |
| 01/31/2008 | US20080027056 Substituted heterocyclic ethers and their use in cns disorders |
| 01/31/2008 | US20080027055 1-Substituted indoles, and benzimidazoles additionally substituted with an amino ligand, e.g., 1-[(5-chlorothien-2-yl)sulfonyl]-5-[2-(piperidin-1-yl)ethoxy]-1H-indole; treating schizophrenia, depression, attention deficit disorder, Alzheimer's disease and Parkinson's disease |
| 01/31/2008 | US20080027051 Novel Heteroaryl Substituted Benzoxazoles |
| 01/31/2008 | US20080027049 Benzofurans as potassium ion channel modulators |
| 01/31/2008 | US20080027041 Pyridizinone derivatives |
| 01/31/2008 | US20080027039 e.g. N-methyl-{1-[1-(2-fluorophenethyl)piperidin-4-yl]-1H-indol-6-yl}acetamide having serotonin receptor antagonist activity; olanzapine, risperidone, perospirone, quetiapine, clocapramine, carpipramine, mosapramine, chlorpromazine,levomeromazine, trazodone, imipramine, paroxetine, fluoxamine etc |
| 01/31/2008 | US20080027032 Combinations comprising cox-2 inhibitors and aspirin |
| 01/31/2008 | US20080027029 Cold menthol receptor-1 antagonists |
| 01/31/2008 | US20080026402 Hematopoietin receptors HPR1 and HPR2 |
| 01/31/2008 | US20080026086 Synergistic Neuroprotective, Combinations Of Flavanols, Hydroxystilbenes, Flavanones, Flavones, Flavonols, Proanthocyanidins And Anthocyanidins |
| 01/31/2008 | US20080026081 Methods of Treatment Using (+)-Isopropyl 2-Ethoxyethyl-4-(2-Chloro-3-Cyano-Phenyl)-1,4-Dihydro-2,6-Dimethyl-Pyridine-3,5-Dicarboxylate |
| 01/31/2008 | US20080026073 Method and composition for lithium additive in treatment of glutamate toxicity |
| 01/31/2008 | US20080026070 Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications |
| 01/31/2008 | US20080026059 Methods of Reducing Degradant Formation in Pharmaceutical Compositions of Varenicline |
| 01/31/2008 | US20080026052 Oral Dosage Forms with Therapeutically Active Agents In Controlled Release Cores and Immediate Release Gelatin Capsule Coats |
| 01/31/2008 | US20080026042 Preoperative Treatment of Post Operative Pain |
| 01/31/2008 | US20080026031 Implantable polymeric device for sustained release of buprenorphine |
| 01/31/2008 | US20080026003 Methods for inhibiting pain |
| 01/31/2008 | US20080026000 Nicotine hapten where nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization; preventing nicotine addiction |
| 01/31/2008 | US20080025988 Monoclonal Antibody And Use Thereof |
| 01/31/2008 | US20080025979 Programmed Death 1(PD-1); bispecific antibodies comprising antibodies against human T cell receptor complex or human B cell receptor complex; autoimmune diseases |
| 01/31/2008 | US20080025978 High affinity ligand for p75 neurotrophin receptor |
| 01/31/2008 | US20080025969 Treatment of Neurodegenerative Diseases by the Use of Gpr49 |
| 01/31/2008 | US20080025963 Compositions and methods for the treatment of CNS injuries |
| 01/31/2008 | US20080025962 Remedy for Alzheimer's Disease |
| 01/31/2008 | US20080025961 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory |
| 01/31/2008 | US20080025959 Permeability of blood-brain barrier |
| 01/31/2008 | US20080025944 Combination Therapy for Immunostimulation |
| 01/31/2008 | CA2659242A1 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory |
| 01/31/2008 | CA2659192A1 Substituted heterocyclic ethers and their use in cns disorders |
| 01/31/2008 | CA2658821A1 Pyridizinone derivatives and uses thereof to treat diseases, disorders and/or conditions that may be mediated or modulated by inhibition of h3 receptors |
| 01/31/2008 | CA2658245A1 Systems and methods to treat pain locally |
| 01/31/2008 | CA2658204A1 Human artificial chromosome (hac) vector and human cell medicine comprising same |
| 01/31/2008 | CA2658037A1 Prodrug of cinnamide compound |
| 01/31/2008 | CA2657563A1 Post-translationally modified neurotrophins |
| 01/31/2008 | CA2656716A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 01/30/2008 | EP1882697A1 Post-translationally modified neurotrophins |
| 01/30/2008 | EP1882690A2 A process for the preparation of epothilone analogs and intermediates |
| 01/30/2008 | EP1882687A1 Heterocyclic compounds useful as vanilloid receptor antagonists and pharmaceutical compositions containing the same |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1881979A1 Novel oxadiazole derivatives and their medical use |
| 01/30/2008 | EP1881975A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 01/30/2008 | EP1881962A2 Thiosuccinic acid derivatives and the use thereof |
| 01/30/2008 | EP1881826A1 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2) |
| 01/30/2008 | EP1521757B1 tricyclic spiropiperidines or spiropyrrolidines |
| 01/30/2008 | EP1399471B1 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
| 01/30/2008 | CN101115753A Bridged ring nk1 antagonists |
| 01/30/2008 | CN101115751A Tricyclic delta-opioid modulators |
| 01/30/2008 | CN101113450A Neurotrophic factor |
| 01/30/2008 | CN101113449A Neurotrophic factor |
| 01/30/2008 | CN101113172A Anti-opium peptide and antagonistic peptide and its application |
| 01/30/2008 | CN101112597A Chinese traditional medicine preparations for treating alleosis during puerperium |
| 01/30/2008 | CN101112580A Traditional Chinese medicine for treating headache |
| 01/30/2008 | CN101112577A Chinese traditional medicine for health care pillow |
| 01/30/2008 | CN101112536A Oral Chinese traditional medicine composition for treating typhoid fever headache |
| 01/30/2008 | CN101112510A Pearl soup Chinese traditional medicine for treating hyperkinetic symptom |
| 01/30/2008 | CN101112508A Chinese traditional medicine for treating children attention deficit disorder |
| 01/30/2008 | CN101112489A Chinese traditional medicine composition for treating alleosis during puerperium |
| 01/30/2008 | CN101112474A Chinese herbal medicine preparations for treating cerebral pasly through immersion |
| 01/30/2008 | CN101112473A Medicine for treating damp-heat, dizziness, headache, deaf, tinnitus and intra-auricular purulence and method for preparing the same |
| 01/30/2008 | CN101112472A Plaster for treating facial palsy and the preparing method thereof |
| 01/30/2008 | CN101112465A Maoyan' berry effervescence tablets and production process thereof |
| 01/30/2008 | CN101112462A Composition of the compatibility of blueberry fruit and vine seed with sour jujube kernel and tuckahoe |
| 01/30/2008 | CN101112367A Antidepressant and uses thereof |
| 01/30/2008 | CN100365118C Schizophrenia related nucleic acid sequence |
| 01/30/2008 | CN100365110C Sedative kidney-reinforcing medicinal liquor |
| 01/30/2008 | CN100364973C Indolone-acetamide derivatives, processes for preparing them and their uses |
| 01/30/2008 | CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors |
| 01/30/2008 | CN100364961C Phenoxyhydrindone derivatives containing nitrogen and preparation and use thereof |
| 01/30/2008 | CN100364578C Plaster for treating facial palsy, rheumatism and prosopalgia and its production process |
| 01/30/2008 | CN100364557C Method for preparing confervoide oil and medicine containing thereof |
| 01/30/2008 | CN100364556C Application of H. seniavinii in preparation of weight-reducing food |
| 01/30/2008 | CN100364555C Application of H. seniavinii in preparation of food for resisting depression or/and promoting memory for learning |
| 01/30/2008 | CN100364554C Preparation method of ganoderma lucidum chewable tablet and product |
| 01/30/2008 | CN100364539C Application of tianeptine in preparation of medicine for treating or preventing MDMA nerve toxicity |
| 01/30/2008 | CN100364526C Application of bicychol in preparation of medicine for preventing and/or treating acute alcoholism and acute/chronic alcoholic liver injury |
| 01/30/2008 | CN100364519C Chewing tablet of tramado hydrochloride and its preparation method |
| 01/30/2008 | CN100364501C Pharmaceutical composition of topiramate |
| 01/29/2008 | US7323587 Selective estrogen receptor modulators |
| 01/29/2008 | US7323585 Levodopa prodrugs, and compositions and uses thereof |
| 01/29/2008 | US7323569 N-cyclopropylmethyl-N-7-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2-ethylpyrazolo[1,5-a]pyridin-3-yl-N-tetrahydro-2H-4-pyranylmethylamine. |
| 01/29/2008 | US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 01/29/2008 | US7323487 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323486 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 01/29/2008 | US7323478 Phenylcycloalkylmethylamino and phenylalkenylamino derivatives, including 1-phenyl-2-aminomethylcyclopropanes; therapy of metabolic, feeding, and sexual disorders including obesity |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
| 01/29/2008 | US7323473 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for treatment of obesity |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323467 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |